Search Results 11-20 of 18410 for Relapse

  1. A Study to Assess Older Adults Applying Pre-transplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality After Allogeneic Transplant (CHARM) - Mayo Clinic

    A Study to Assess Older Adults Applying Pre-transplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality After Allogeneic ...

  2. Relapse Prediction Following Discontinuation of Tocilizumab In Giant Cell Arteritis - Mayo Clinic

    Relapse Prediction Following Discontinuation of Tocilizumab In Giant Cell Arteritis · Overview · Participation eligibility · Participating Mayo Clinic locations.

  3. Root Cause of Multiple Myeloma Relapse Revealed - Mayo Clinic News Network

    Collaborating with colleagues at Princess Margaret Cancer Centre in Toronto, researchers from Mayo Clinic in Arizona and the Translational Genomics Research ...

  4. Research Team Uncovers Root Cause Of Multiple Myeloma Relapse

    ... relapse. The research demonstrates that although the visible cancer cells that make up most of the tumor are sensitive to the proteasome inhibitor drug, the ...

  5. Multiple sclerosis - Diagnosis and treatment - Mayo Clinic

    This treatment is a monoclonal antibody that decreases annual relapse rates and demonstrates MRI benefits. This medicine helps reduce relapses of MS by ...

  6. Drug Addiction Clinical Trials - Mayo Clinic Research

    ... relapses or slips. A Study to Evaluate AAV8-human Cocaine Hydrolase to ... Relapse in Subjects with Substance Use Disorders Rochester, MN. Impulsivity ...

  7. A Study to Evaluate Heart Rate Variability in Alcohol-dependent Subjects in Treatment - Mayo Clinic

    Persistent low treatment rates and high relapse rates indicate the need for more research in treatment of alcoholism. It is well known that craving is a ...

  8. Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML - Mayo Clinic

    About this study. To determine if the addition of midostaurin (PKC412) to Standard of Care (SOC) therapy reduces relapse in FLT3-ITD mutated AML patients ...

  9. Multiple sclerosis - Symptoms and causes - Mayo Clinic

    These relapses are followed by quiet periods of disease remission that can last months or even years. Secondary-progressive MS. At least 20% to 40% of people ...

  10. Medical Research & Education - Mayo Clinic News Network

    ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...